Environmental Disrupters, Lung Disease and Cancer

Chronic inflammation can be caused by both intrinsic and extrinsic factors.  This 75 minute webinar will explore the newest research describing how chronic inflammation can promote lung disease and cancer, with emphasis on emerging therapeutic approaches that promote resolution of inflammation.

In This Webinar, You'll Learn

• The intrinsic and extrinsic factors (including tobacco smoke and pollution) that drive chronic inflammation and can contribute to pro-tumorigenic environments.
• How pro-resolving pathways are compromised in cancer and chronic lung diseases such as fibrosis and COPD.
• How modulating resolution pathways could lead to the development of new therapies with high efficacy and fewer side effects.

Patricia Sime, MD
Virginia Commonwealth University

Patricia J. Sime received her MD training at the University of Edinburgh, Scotland, followed by training in the biology of scarring diseases at McMaster University, Canada. In 1999, she was recruited as faculty at the University of Rochester as a physician, educator and researcher. In 2019 she assumed the position as Chair of the Department of Internal Medicine at Virginia Commonwealth University. Dr. Sime leads a team of outstanding physicians and researchers focused on understanding the mechanisms and therapy of fibrotic lung diseases. She receives funding from the National Institutes of Health, the Department of Defense, Industry and Philanthropy.

Dipak Panigrahy, MD
Harvard Medical School

Dipak Panigrahy was accepted to medical school while still in high school at age 17, and graduated from the combined BA/MD program at Boston University Medical School. He trained with Roger Jenkins, who performed the 1^st liver transplant in Boston. As a student and during his surgical training, Dr. Panigrahy worked closely with Judah Folkman, the father of angiogenesis, to develop mouse models for the study of tumor angiogenesis and angiogenesis-dependent regeneration. Dr. Panigrahy’s laboratory has published several studies in the emerging field of endogenous anti-inflammatory lipid autacoids such as resolvins and their role in inflammation resolution in cancer.

Access to Webinar Materials

A link to the eBriefing (video recording) of this Webinar will be available to all registrants within 30 days of the event date.  The eBriefing will be available to all registrants for 60 days following publication, after which it will revert to Member-only access. Not a Member? Join today.